Search results
Alison Lawton (born May 29, 1970) is a Canadian social venture philanthropist, social advocate, and business investor.
Alison Lawton most recently served as Kaleido’s Chief Executive Officer, President and as a member of the Board of Directors since August 2018, after initially joining the company as President and Chief Operating Officer in December 2017.
View Alison Lawton’s profile on LinkedIn, a professional community of 1 billion members. Seasoned Biotech Executive with experience as CEO, Chair and independent director of…
Jun 25, 2024 · Alison Lawton is an experienced biopharma executive and a board member of Dianthus Therapeutics, a company developing gene therapy for rare diseases. She has also served as CEO of Kaleido Biosciences and COO of Aura Biosciences, among other roles.
Alison Lawton’s departure from the CEO post is explained as follows. Kaleido said: “Alison Lawton has chosen to step down from her position as President and Chief Executive Officer in order to return to the United Kingdom and attend to an unexpected family health matter.
Jun 13, 2023 · VANCOUVER, British Columbia, June 13, 2023 (GLOBE NEWSWIRE) -- The Mindset Social Innovation Foundation is thrilled to announce the appointment of its founder, Alison Lawton, to the World...
Ms. Lawton currently serves as a special advisor and board member at Kaleido Biosciences, Inc., and as an independent director of ProQR Therapeutics N.V. Previously, she served as Kaleido’s Chief Executive Officer, after initially joining the company as President and Chief Operating Officer.
